Artwork

Innhold levert av Mtech Access. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Mtech Access eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!

What's happening with specialised commissioning in the NHS?

1:00:08
 
Del
 

Manage episode 400570631 series 3381584
Innhold levert av Mtech Access. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Mtech Access eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

What’s happening with specialised commissioning in the NHS? How likely is a delay in delegation to integrated care boards (ICBs)? How and what should Pharma and Medtech plan for amidst all this uncertainty?
Malcolm Qualie (former Medicines Lead for Specialised Services, NHS England) speaks to David Thorne (Principal Associate, Mtech Access) to explore specialised commissioning in the NHS and what to expect as we head into 2024.
Malcolm Qualie and David Thorne explored:

  • Specialised commissioning in the NHS
  • The risks and opportunities that devolution to ICBs will bring
  • What we can expect to see in the short and longer term
  • How industry can support ICB leaders through this transition
  • How Pharma, Medtech, and Diagnostics companies, whose products come under specialised commissioning, can manage these risks and uncertainties

Learn more at https://mtechaccess.co.uk/nhs-specialised-commissioning/
This episode first broadcast as a live webinar in Decmeber 2023.

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

  continue reading

58 episoder

Artwork
iconDel
 
Manage episode 400570631 series 3381584
Innhold levert av Mtech Access. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Mtech Access eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

What’s happening with specialised commissioning in the NHS? How likely is a delay in delegation to integrated care boards (ICBs)? How and what should Pharma and Medtech plan for amidst all this uncertainty?
Malcolm Qualie (former Medicines Lead for Specialised Services, NHS England) speaks to David Thorne (Principal Associate, Mtech Access) to explore specialised commissioning in the NHS and what to expect as we head into 2024.
Malcolm Qualie and David Thorne explored:

  • Specialised commissioning in the NHS
  • The risks and opportunities that devolution to ICBs will bring
  • What we can expect to see in the short and longer term
  • How industry can support ICB leaders through this transition
  • How Pharma, Medtech, and Diagnostics companies, whose products come under specialised commissioning, can manage these risks and uncertainties

Learn more at https://mtechaccess.co.uk/nhs-specialised-commissioning/
This episode first broadcast as a live webinar in Decmeber 2023.

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

  continue reading

58 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett